Loading...

Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication.

Fifty-one men with atherosclerotic intermittent claudication and haemorheological abnormalities completed a double-blind, one-year randomised trial of Ticlopidine (500 mg/day), a new antiplatelet agent. Ticlopidine caused significant inhibition of platelet aggregation but did not fully correct abnor...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Pathol
Main Authors: Aukland, A, Hurlow, R A, George, A J, Stuart, J
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 1982
Fag:
Online adgang:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC497768/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7047575/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jcp.35.7.740
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!